Abstract 143: Multi-omics Integration From A Large Human Biobank Identifies Key Molecular Mechanisms And Signatures Of Atherosclerotic Plaque Instability
Vivek Das,Xiang Zhang,Djordje Djordjevic,Otto Bergman,Sampath Narayanan,Dmitry Shungin,Melody Chemaly,Glykeria Karadimou,Sofija Vuckovic,Inika Prasad,Karin Conde Knape,Natasha Barascuk Michaelsen1,Ulf Hedin,Ljubica Matic
DOI: https://doi.org/10.1161/atvb.44.suppl_1.143
2024-05-01
Abstract:Understanding the pathophysiology of unstable atherosclerosis, the underlying cause of myocardial infarction and ischemic stroke, is imperative to catalyze novel translational strategies. Our objective was to identify key mechanisms and signatures of atherosclerotic instability, by leveraging the power of multi-omics integration from a large biobank. Biobank of Karolinska Endarterectomies (BiKE), with biomaterial and data from patients with symptomatic (S) and asymptomatic (AS) carotid atherosclerosis, was the main resource in this study. Matched plaques, PBMCs, plasma sampled locally around the plaque and from the periphery in n>600 individuals, were profiled by orthogonal genomic, transcriptomic, proteomic and metabolomic technologies. Single-omics analyses were performed for differential expression, pathway and network studies in S vs. AS comparisons. Multi-omics integration was performed using a benchmarked method DIABLO, across local and peripheral disease sites and their intersection. Top targets were investigated further using scRNAseq, patient clinical and outcome data, as well as QTL analyses coupling target genetics with transcript, protein, and metabolite levels. Plaque and PBMC transcriptomics showed that inflammatory signalling, hypoxia, angiogenesis, ECM reorganisation, bone remodelling, cholesterol homeostasis, glycolysis were enriched pathways. In proteomics, chemokine signalling upregulation was found in both peripheral and local plasma, while IL17 pathway was enriched in local plasma from S patients. In plasma metabolomics, Bilirubin degradation products were downregulated, while Sphingomyelins were upregulated. Multi-omics integrations revealed coagulation, necroptosis, immune activation and cholesterol metabolism as key pathways determining instability. Extended analyses of the top analytes FABP4, ICOSLG, ANGPTL3, Bilirubin and Sphingomyelins, generated an insight into their association with survival, clinical and genetic risk in patients. Using an innovative framework, this study brings novel information about atherosclerosis vulnerability, opening avenues for drug target and biomarker discoveries, but also improving personalised treatment options and risk stratifications.
peripheral vascular disease,hematology